Biocompatible Aloe vera and Tetracycline Hydrochloride Loaded Hybrid Nanofibrous Scaffolds for Skin Tissue Engineering.
Aloe
/ chemistry
Anti-Bacterial Agents
/ administration & dosage
Biocompatible Materials
/ chemistry
Biomarkers
Cell Proliferation
Cell Survival
Drug Liberation
Fibroblasts
Humans
Materials Testing
Mechanical Phenomena
Microbial Sensitivity Tests
Nanofibers
/ chemistry
Skin
Spectrum Analysis
Tetracycline
/ administration & dosage
Tissue Engineering
Tissue Scaffolds
/ chemistry
Wound Healing
aloe vera
curcumin
electrospinning
fibroblasts
nanofibers
tetracycline hydrochloride
wound healing
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
18 Oct 2019
18 Oct 2019
Historique:
received:
20
09
2019
revised:
16
10
2019
accepted:
16
10
2019
entrez:
23
10
2019
pubmed:
23
10
2019
medline:
4
3
2020
Statut:
epublish
Résumé
Aloe vera (AV) and tetracycline hydrochloride (TCH) exhibit significant properties such as anti-inflammatory, antioxidant and anti-bacterial activities to facilitate skin tissue engineering. The present study aims to develop poly-ε-caprolactone (PCL)/ AV containing curcumin (CUR), and TCH loaded hybrid nanofibrous scaffolds to validate the synergistic effect on the fibroblast proliferation and antimicrobial activity against Gram-positive and Gram-negative bacteria for wound healing. PCL/AV, PCL/CUR, PCL/AV/CUR and PCL/AV/TCH hybrid nanofibrous mats were fabricated using an electrospinning technique and were characterized for surface morphology, the successful incorporation of active compounds, hydrophilicity and the mechanical property of nanofibers. SEM revealed that there was a decrease in the fiber diameter (ranging from 360 to 770 nm) upon the addition of AV, CUR and TCH in PCL nanofibers, which were randomly oriented with bead free morphology. FTIR spectra of various electrospun samples confirmed the successful incorporation of AV, CUR and TCH into the PCL nanofibers. The fabricated nanofibrous scaffolds possessed mechanical properties within the range of human skin. The biocompatibility of electrospun nanofibrous scaffolds were evaluated on primary human dermal fibroblasts (hDF) by MTS assay, CMFDA, Sirius red and F-actin stainings. The results showed that the fabricated PCL/AV/CUR and PCL/AV/TCH nanofibrous scaffolds were non-toxic and had the potential for wound healing applications. The disc diffusion assay confirmed that the electrospun nanofibrous scaffolds possessed antibacterial activity and provided an effective wound dressing for skin tissue engineering.
Identifiants
pubmed: 31635374
pii: ijms20205174
doi: 10.3390/ijms20205174
pmc: PMC6834217
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Biocompatible Materials
0
Biomarkers
0
Tetracycline
F8VB5M810T
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministry of Education - Singapore
ID : R-181-000-184-114
Références
Eur Spine J. 2008 Dec;17 Suppl 4:467-79
pubmed: 19005702
Materials (Basel). 2015 Aug 11;8(8):5154-5193
pubmed: 28793497
Nat Rev Mol Cell Biol. 2011 Aug 23;12(9):565-80
pubmed: 21860392
Braz Dent J. 2009;20(5):414-8
pubmed: 20126911
Int J Mol Sci. 2017 Apr 07;18(4):
pubmed: 28387714
Biomaterials. 2013 Jan;34(3):724-34
pubmed: 23111334
PLoS One. 2013 Sep 13;8(9):e74779
pubmed: 24058626
Prog Biomater. 2018 Mar;7(1):23-33
pubmed: 29196898
Adv Mater. 2009 Sep 4;21(32-33):3343-51
pubmed: 20882501
Clin Plast Surg. 2017 Jul;44(3):635-650
pubmed: 28576253
J Polym Sci B Polym Phys. 2011 Jun 15;49(12):832-864
pubmed: 21769165
J Funct Biomater. 2018 Aug 21;9(3):null
pubmed: 30134538
Int J Nanomedicine. 2016 Sep 02;11:4339-55
pubmed: 27621626
Eur Rev Med Pharmacol Sci. 2012 Sep;16(9):1222-6
pubmed: 23047506
Biomed Res Int. 2014;2014:921905
pubmed: 25143954
Cell Mol Life Sci. 2012 Aug;69(15):2469-83
pubmed: 22349211
BMB Rep. 2016 Jan;49(1):26-36
pubmed: 26497579
J Biomater Sci Polym Ed. 2017 Jun;28(8):730-748
pubmed: 28285576
J Funct Biomater. 2017 Feb 14;8(1):
pubmed: 28216559
Adv Wound Care (New Rochelle). 2015 Mar 1;4(3):119-136
pubmed: 25785236
Nanomaterials (Basel). 2019 Mar 20;9(3):null
pubmed: 30897714
Wounds. 2008 Dec;20(12):347-56
pubmed: 25941895
Br J Pharmacol. 2013 May;169(2):337-52
pubmed: 23441623
Biomed Res Int. 2014;2014:186864
pubmed: 24877064
Sci Rep. 2018 Apr 19;8(1):6248
pubmed: 29674743
Materials (Basel). 2016 Apr 07;9(4):null
pubmed: 28773397
Stem Cell Res Ther. 2018 Nov 8;9(1):302
pubmed: 30409218
PLoS One. 2014 Feb 28;9(2):e89761
pubmed: 24587017
Chonnam Med J. 2011 Apr;47(1):1-13
pubmed: 22111050
BMC Res Notes. 2017 Jan 25;10(1):60
pubmed: 28118858
Int Immunopharmacol. 2014 Jun;20(2):322-30
pubmed: 24675438
Stem Cell Res Ther. 2016 Mar 09;7:37
pubmed: 26960535
Indian J Dermatol. 2008;53(4):163-6
pubmed: 19882025